title: Chronic lymphocytic leukemia: recommendations.
authors.forename: B D
authors.initials: BD
authors.lastname: Cheson
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: K R
authors.initials: KR
authors.lastname: Rai
authors.forename: M R
authors.initials: MR
authors.lastname: Grever
authors.forename: N E
authors.initials: NE
authors.lastname: Kay
authors.forename: M M
authors.initials: MM
authors.lastname: Oken
authors.forename: C A
authors.initials: CA
authors.lastname: Schiffer
authors.forename: M J
authors.initials: MJ
authors.lastname: Keating
authors.forename: D H
authors.initials: DH
authors.lastname: Boldt
authors.forename: S J
authors.initials: SJ
authors.lastname: Kempin
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007391:International Cooperation; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000188:drug therapy; D009316:National Institutes of Health (U.S.); D014481:United States